Evidence guides
Read the outcome, then its boundaries.
These four guides examine the exact RENOVA label, fine and deeper wrinkle language, photograph context and the place of sun protection in the evidence.
Guide
Read RENOVA’s fine-facial-wrinkle indication with its limits
The exact 0.02% cream record describes an additional role within a wider care program.
Guide
Fine lines and deeper wrinkles ask different evidence questions
Describe the concern without assuming that broad anti-aging language answers it.
Guide
What a fine-line photograph can show—and what it cannot prove
Image conditions, observers and concurrent care all affect how a comparison should be read.
Guide
Why sun protection belongs in the fine-line evidence discussion
RENOVA’s wider care context and current AAD guidance answer related but different questions.
Guide
Tretinoin Strength, Fine Lines, and Irritation: What 48 Weeks Actually Measured
A comparison of 0.1% and 0.025% tretinoin found similar observed facial improvement but more irritation at the higher strength. Its striking tissue percentages describe microscopy—not percent wrinkle reduction.
Guide
Retinol in Adults Averaging 87: What a 24-Week Arm Study Measured
A small controlled trial found better wrinkle scores and tissue-marker changes with 0.4% retinol. Its strongest lesson is how to separate visible improvement, microscopic findings, and claims the experiment never tested.